Asian Pacific Journal of Cancer Prevention

  • 제13권5호
  • /
  • Pages.1757-1760
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Down-Regulation of CYP1A1 Expression in Breast Cancer

  • Hafeez, S. (Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology) ;
  • Ahmed, A. (Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology) ;
  • Rashid, Asif Z. (Department of Surgery, Military Hospital) ;
  • Kayani, Mahmood Akhtar (Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology)
  • 발행 : 2012.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Breast cancer is a major cause of death in women worldwide. Mammary tissue expressing xenobiotic metabolizing enzymes metabolically activate or detoxify potential genotoxic breast carcinogens. Deregulation of these xenobiotic metabolizing enzymes is considered to be a major contributory factor to breast cancer. The present study is focused on the expression of the xenobiotic metabolizing gene, CYP1A1, in breast cancer and its possible relationships with different risk factors. Twenty five tumors and twenty five control breast tissue samples were collected from patients undergoing planned surgery or biopsy from different hospitals. Semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and western-blotting were used to investigate the expression of CYP1A1 in breast cancer control and disease samples. mRNA expression of CYP1A1 was down-regulated in 40% of breast tumor samples. Down-regulation was also observed at the protein level. Significnat relations were noted with marital status and tumour grade but not histopathological type. In conclusion, CYP1A1 protein expression was markedly reduced in tumor breast tissues samples as compared to paired control tissue samples.

키워드

참고문헌

  1. Aslam M, Ansari A, Siddique A, Imran M (2006). Carcinoma breast, late presentation-a big concern. Ann King Edward Med Coll, 2, 317-29.
  2. Abdel R, Corcos A, Fautrel J, Campion H, Guillouze J (1994). Transforming growth factors ß1down regulation basal and poly cyclic armomatic hydro carbons induced cytochrome p450 1A1 and1A2 in adult human hepatocytes in primary culture. Mol Pharmacol, 46, 1100-10
  3. Baloch T, Iqbal P (2006). Breast carcinoma in Karachi Clinical & Pathological Features. Med Channel, 12, 47-58.
  4. Bernauer U, Heinrich H, Tonnies M, Peter Mathias W, Gunert- Remy U (2006). Characterization of the xenobiotic metabolizing cytochrome p450 expression pattern in human lung tissue by immunochemical and activity determination. Toxi-col Lett, 164, 278-88. https://doi.org/10.1016/j.toxlet.2006.01.007
  5. Batool M, Arian M, Gardezi J (2005). An experience with breast disease in a surgical unit of a teaching hospital of Lahore. Biomedica, 21, 108-12.
  6. Bhurgri Y (2004). Karachi Cancer Registry data-implications for the national cancer control program of Pakistan. Asian Pac J Cancer Prev, 5, 77-82.
  7. Conway D, Sakurai Y, Weiss D (2009). Expression of CYP1A1 and CYP1B1 in human endothelial cells,regulation by fluid shear stress. Cardiovasc Res, 81, 669-77. https://doi.org/10.1093/cvr/cvn360
  8. El-Rayes B, Ali S, Heilburn L (2003). Cytochrome p450 and glutathione s transferase expression in human breast cancer. Clin Cancer Res, 9, 1705-9.
  9. Forbes J (1997). The incidence of breast cancer: the global burden, public healthconsiderations. Sem Oncol, 24, 20-35.
  10. Gilani G, Kamal S, Akhter A (2003). A differential study of breast cancer patients in Punjab, Pakistan. J Pak Med Assoc, 53, 478-81.
  11. Gonzalez F, Gelbion H (1994). Role of human cytochrome P450 in the metabolicactivation of chemical carcinogens and toxins. Drug Metab, 26, 165-83. https://doi.org/10.3109/03602539409029789
  12. Hildebrant A, Berg C, Heinemeyer G (1981). Studies on the mechanism of stimulation of microsomal $H_{2}O_{2}$ formation and benzo (a)pyrene hyroxlation by substrate and flavones. Adv Exp Med Biol, 136, 179-98.
  13. Jorgensen K, Gøtzsche P (2004). Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. J Med Genet, 328,148-51.
  14. Kelsey J, Horn R (2007). Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev, 35, 7-16.
  15. Klonoff-Cohen H, Schaffroth L, Edelstein S, Molgaard C, Saltzstein S (1998). Breast cancer histology in Caucasians, African Americans, Hispanics, Asians, and Pacific Islanders. Ethn Health, 3, 89-98.
  16. Li D, Wang M, Dhingra K, Hittelman W (1996). Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res, 56, 287-93.
  17. Laemmili (1970). Clevage of structural protein during the assembly of the head of bacteriphage. T4, 277, 680-5.
  18. Martin F, Cole K, Harvey D, et al (2000). DNA damage in human breast milk cells and its induction by "early" and "late" milk extracts. Carcinogenesis, 21, 799-804. https://doi.org/10.1093/carcin/21.4.799
  19. Malfatti M, Kulp K, Knize M, et al (1999). The identification of [2-(14) C] 2-amino-1-methyl-pheny limidazo[4,b] pyridine metabolites in humans. Carcinogenesis, 20, 705-13. https://doi.org/10.1093/carcin/20.4.705
  20. Morel Y, Barouki R (1998). Down regulation of cytochrome p40 1A1 gene promoter by oxidative stress:critical contribution of NF1. J Biol Chem, 273, 26969-76. https://doi.org/10.1074/jbc.273.41.26969
  21. Michele C, William G, Angus R, et al (1998). Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelail cell:Role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res, 58, 2366-74.
  22. Martin F, Carmicheal P, Crofton S, et al (1996). Genotoxicity of human mammary lipid. Cancer Res, 56, 5342-6.
  23. Murray G, Taylor V, Mckay J (1995). Expression of xenobiotic metabolizing enzymes in tumor of urinary bladder. Int J Exp Patgol, 76, 271-6.
  24. Murray G, Shaw D, Weaver R (1994). Cytochrome p450 expression in oesophageal cancer. Gut, 35, 599-603. https://doi.org/10.1136/gut.35.5.599
  25. Nosheen M, Malik F, Kayani MA (2011). Genetic variations in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pacific J Cancer Prev, 12, 1-5.
  26. Paton T, Renton W (1998). Cytokine mediated down regulation of CYP1A1 in Hepa 1 cells. Biochem Pharmacol, 55, 1791-6. https://doi.org/10.1016/S0006-2952(98)00028-8
  27. Puga A, Ma C, Marlowe J (2009). The aryl hydrocarbon receptors cross talks with multiple signal transduction pathways. Pharmacal, 77, 713-22.
  28. Pompon D, Perret A, Laine R (1997). Molecular mechanism of modulation of the oxidative stress generated by uncoupling of P450 cytochrome. In Abstract of the 1st international work shop on free radicals in liver metabolism and disease, France.
  29. Pavek P, Dvorak Z (2008). Xenobiotic -induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome p450 superfamily in human extrahepatic tissue. Drug Metab, 9, 129-43. https://doi.org/10.2174/138920008783571774
  30. Qureshi S, Ghazanfar S, Memon S, Attaullah Q, Sultan N (2007). Five years experience of carcinoma breast. J Surg Pak, 12, 52-7.
  31. Sasco A (2001). Epidemiology of breast cancer: an environmental disease? APMIS, 109, 321-32. https://doi.org/10.1034/j.1600-0463.2001.090501.x
  32. Siddiqui M, Kayani N, Sulaiman S, et al (2000). Breast carcinoma in Pakistani females: a morphological study of 572 breast specimens. J Pak, 50, 174-7.
  33. Wei C, Caccavale R, Kehce K (2001). CP1A1 is expressed with CYP1A2 in the lungs cancer. Cancer Lett, 171, 113-20. https://doi.org/10.1016/S0304-3835(01)00529-8
  34. Whyatt R, Garte S, Cosma G (1995). CYP1A1 mRNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarker Prev, 4, 147-53.

피인용 문헌

  1. Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer vol.17, pp.10, 2016, https://doi.org/10.3390/ijms17101726